Department of Pediatrics, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):107-12. doi: 10.1161/CIRCEP.113.000426. Epub 2013 Dec 20.
A school-based electrocardiographic screening program has been developed in Japan. However, few data are available on the genetic characteristics of pediatric patients with long-QT syndrome who were diagnosed by this program.
A total of 117 unrelated probands aged ≤18 years were the subjects who were referred to our centers for genetic testing. Of these, 69 subjects diagnosed by the program formed the screened group. A total of 48 subjects were included in the clinical group and were diagnosed with long-QT syndrome-related symptoms, familial study, or by chance. Mutations were classified as radical, of high probability of pathogenicity, or of uncertain significance. Two subjects in the clinical group died. Genotypes were identified in 50 (72%) and 23 (48%) of subjects in the screened and clinical groups, respectively. Of the KCNQ1 or KCNH2 mutations, 31 of 33 (94%) in the screened group and 15 of 16 (94%) in the clinical group were radical and of high probability of pathogenicity. Prevalence of symptoms before (9/69 versus 31/48; P<0.0001) and after (12/69 versus 17/48; P=0.03) diagnosis was significantly lower in the screened group when compared with that in the clinical group although the QTc values, family history of long-QT syndrome, sudden death, and follow-up periods were not different between the groups.
These data suggest that the screening program may be effective for early diagnosis of long-QT syndrome that may allow intervention before symptoms. In addition, screened patients should have follow-up equivalent to clinically identified patients.
日本已经开发出一种基于学校的心电图筛查计划。然而,通过该计划诊断出的儿科长 QT 综合征患者的遗传特征相关数据较少。
共有 117 名年龄≤18 岁的无血缘关系的先证者作为研究对象,被转诊到我们的中心进行基因检测。其中,69 名通过该计划诊断为患者的形成筛查组。共有 48 名被诊断为长 QT 综合征相关症状、家族研究或偶然发现的患者被纳入临床组。突变分为激进型、高度致病性或意义不确定。临床组中有 2 名患者死亡。在筛查组和临床组中,分别有 50 名(72%)和 23 名(48%)患者确定了基因型。在 KCNQ1 或 KCNH2 突变中,筛查组的 33 个中的 31 个(94%)和临床组的 16 个中的 15 个(94%)为激进型和高度致病性。虽然 QTc 值、长 QT 综合征家族史、猝死和随访期在两组之间没有差异,但筛查组在诊断前(9/69 与 31/48;P<0.0001)和诊断后(12/69 与 17/48;P=0.03)出现症状的患病率明显低于临床组。
这些数据表明,该筛查计划可能对长 QT 综合征的早期诊断有效,从而可以在出现症状之前进行干预。此外,筛查患者应进行与临床确诊患者相当的随访。